DGX — Quest Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $14.26bn
- $18.53bn
- $9.25bn
- 86
- 59
- 72
- 84
Annual cashflow statement for Quest Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 906 | 1,499 | 2,080 | 1,015 | 908 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -42 | 38 | -285 | 146 | 119 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 35 | 22 | 87 | 119 | -145 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 1,243 | 2,005 | 2,233 | 1,718 | 1,272 |
| Capital Expenditures | -400 | -418 | -403 | -404 | -408 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -11 | -354 | 424 | -139 | -653 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -411 | -772 | 21 | -543 | -1,061 |
| Financing Cash Flow Items | -87 | -29 | -159 | -140 | -71 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 225 | -1,267 | -2,540 | -1,732 | 160 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,057 | -34 | -286 | -557 | 371 |